Stay updated on scAAV9.U1a.hSGSH Gene Transfer Clinical Trial
Sign up to get notified when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.

Latest updates to the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0. This appears to be a minor version update with no user-facing content changes.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check21 days agoChange DetectedAdded the MeSH term 'Mucopolysaccharidosis, MPS-III-A' to the study record.SummaryDifference0.0%

- Check28 days agoChange DetectedAdded a screening threshold: Cohorts 1-3 require anti-AAV9 antibody titers ≥ 1:100 (ELISA) to be considered positive. The previous screening criterion for Cohort 4 antibody positivity at screening has been removed.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.4.2 is now displayed, and the previous government funding/operating-status notice has been removed.SummaryDifference0.4%

Stay in the know with updates to scAAV9.U1a.hSGSH Gene Transfer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.